AIDS and cancer specimen bank at UCSF renamed and funded for five more years

October 28, 2002

The National Cancer Institute has funded for five additional years the AIDS and Cancer Specimen Resource centered at UCSF. AIDS and Cancer Specimen Resource (ASCR) is the new name for the AIDS and Cancer Specimen Bank, a program that has been in existence nine years.

"We have been operating as the country's leading nationwide, and soon international, multi-site collection program that includes a "bank" of specimens for investigators in such fields as HIV/AIDS, related cancer and virology," said Michael S. McGrath, MD, PhD, UCSF professor of laboratory medicine, and principal investigator for the ACSR Central Operations and Data Coordinating Center.

ACSR is expanding its existing specimen program with a broadened scope of collection, new technologies, and a new central coordinating office at UCSF that will manage central database functions, application processing and outreach activities. The office will also address human subject research issues relevant to its services.

"The name change follows a strategic reconfiguration of our operations and more accurately reflects the expansion of our services to researchers. In the future, ACSR will act as an advocate for researchers by seeking out on their behalf materials not currently in ACSR's possession," said McGrath.

Funded by the National Cancer Institute, ACSR is the country's leading multi-site source for well-documented tissue and biological samples and serves investigators working in the fields of HIV/AIDS and cancer, virology, immunology, pathology, epidemiology, tumor biology, and assay development--as well as others. ASCR is a repository for HIV-infected human materials from a wide spectrum of HIV-related or associated diseases--including cancer--and from appropriate HIV-negative controls.

"We have more than one million specimens in our database. Plus, we are coordinating new sources of specimens from around the globe, including China, Thailand, and South America," said McGrath.

Besides operating its large existing specimen bank, ACSR, upon request, searches for and acquires specimens not currently in the bank to meet the special needs of approved investigations. In addition to UCSF, ACSR sites include George Washington University and Ohio State University as well as collaborative sites that together constitute an international network.

A description of the ASCR, available specimens, how to request specimens, as well as contact information are available on the ASCR website,

University of California - San Francisco

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to